Please login to the form below

Not currently logged in
Email:
Password:

FDA

This page shows the latest FDA news and features for those working in and with pharma, biotech and healthcare.

Merck to initiate phase 3 HIV-1 clinical programme with a lower dose of islatravir

Merck to initiate phase 3 HIV-1 clinical programme with a lower dose of islatravir

The US Food and Drug Administration (FDA) has reviewed and agreed with this plan. ... Following extensive evaluations and consultation with FDA, we are pleased to be able to initiate our new phase 3 clinical programme to evaluate islatravir for the

Latest news

More from news
Approximately 890 fully matching, plus 3,087 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 172 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 81 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
The Difference Collective

Welcome to the Difference Collective – a healthcare communications team of 80+ talented experts who Deliver Differently. We’re purpose-built around...

Latest intelligence

Jonathan Cooke
The fight against antimicrobial resistance
By Jonathan Cooke...
How long should my healthcare video be?
This week, Tim took a deeper look at a question we are asked almost daily; how long should my healthcare video be?...
Article: How behavioural economics can help you build better brand communications
For pharma marketers, accelerating brand performance means maximizing return on investment. Your campaigns need to trigger the right emotions, and the right actions, in your audience....